These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34229882)

  • 1. Perniosis-like lesions after vaccination with mRNA against COVID-19.
    Pérez-López I; Gil-Villalba A; Ruiz-Villaverde R
    Med Clin (Barc); 2022 Feb; 158(4):189-190. PubMed ID: 34229882
    [No Abstract]   [Full Text] [Related]  

  • 2. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2.
    Ko CJ; Harigopal M; Damsky W; Gehlhausen JR; Bosenberg M; Patrignelli R; McNiff JM
    J Cutan Pathol; 2020 Nov; 47(11):997-1002. PubMed ID: 32745281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perniosis-like erythema after SARS-CoV2 infection reactivated by vaccination with inactivated virus.
    Campos Garcia L; Barcelos VM; Macedo de Alcântara M; Valadares PJC
    An Bras Dermatol; 2023; 98(4):552-554. PubMed ID: 37003902
    [No Abstract]   [Full Text] [Related]  

  • 4. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
    Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e493-e494. PubMed ID: 33914966
    [No Abstract]   [Full Text] [Related]  

  • 5. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
    Magro CM; Mulvey JJ; Laurence J; Sanders S; Crowson AN; Grossman M; Harp J; Nuovo G
    Br J Dermatol; 2021 Jan; 184(1):141-150. PubMed ID: 32779733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report.
    Souaid K; Oulès B; Sohier P; Deschamps L; Aractingi S; Dupin N
    Acta Derm Venereol; 2021 Nov; 101(11):adv00589. PubMed ID: 34396420
    [No Abstract]   [Full Text] [Related]  

  • 8. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-related chilblain-like lesions and idiopathic perniosis: Additional variables possibly influencing dermoscopic pattern.
    Errichetti E
    Dermatol Ther; 2021 Jul; 34(4):e14985. PubMed ID: 33993592
    [No Abstract]   [Full Text] [Related]  

  • 10. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
    Lesort C; Kanitakis J; Donzier L; Jullien D
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e630-e632. PubMed ID: 34131969
    [No Abstract]   [Full Text] [Related]  

  • 11. Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study.
    Poizeau F; Oger E; Barbarot S; Le Corre Y; Samimi M; Brenaut E; Aubert H; Chambrelan E; Droitcourt C; Gissot V; Heslan C; Laurent C; Martin L; Misery L; Tattevin P; Toubel A; Thibault V; Dupuy A
    Clin Microbiol Infect; 2022 Feb; 28(2):285-291. PubMed ID: 34619397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auricle perniosis as a manifestation of Covid-19 infection.
    Proietti I; Tolino E; Bernardini N; Mambrin A; Balduzzi V; Marchesiello A; Michelini S; Del Borgo C; Skroza N; Lichtner M; Potenza C
    Dermatol Ther; 2020 Nov; 33(6):e14089. PubMed ID: 32720420
    [No Abstract]   [Full Text] [Related]  

  • 13. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature.
    Jindal R; Chauhan P; Goyal D; Shirazi N
    Dermatol Ther; 2021 May; 34(3):e14951. PubMed ID: 33740317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination.
    Temiz SA; Abdelmaksoud A; Dursun R; Vestita M
    Int J Dermatol; 2021 Sep; 60(9):1152-1153. PubMed ID: 33900629
    [No Abstract]   [Full Text] [Related]  

  • 15. A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine?
    Meara AS; Silkowski M; Quin K; Jarjour W
    J Rheumatol; 2021 Nov; 48(11):1754. PubMed ID: 34210829
    [No Abstract]   [Full Text] [Related]  

  • 16. Chilblain lesions after COVID-19 mRNA vaccine.
    Pileri A; Guglielmo A; Raone B; Patrizi A
    Br J Dermatol; 2021 Jul; 185(1):e3. PubMed ID: 33904168
    [No Abstract]   [Full Text] [Related]  

  • 17. Pernio after COVID-19 vaccination.
    Lopez S; Vakharia P; Vandergriff T; Freeman EE; Vasquez R
    Br J Dermatol; 2021 Aug; 185(2):445-447. PubMed ID: 33893637
    [No Abstract]   [Full Text] [Related]  

  • 18. Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
    Karamanakos A; Evangelatos G; Pappa M; Fragiadaki K; Fanouriakis A; Fragoulis GE
    J Rheumatol; 2022 Nov; 49(11):1295-1296. PubMed ID: 35914789
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.
    Poizeau F; Triquet L; Dupuy A
    Acta Derm Venereol; 2022 Jun; 102():adv00728. PubMed ID: 35506360
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A
    Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.